Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy. - Wikidata - awgldk - TriplyDB

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy.

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q34059719

about

Current operative management of breast cancer: an age of smaller resections and bigger cures.Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator.Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy.Histologic Grade and Decrease in Tumor Dimensions Affect Axillary Lymph Node Status after Neoadjuvant Chemotherapy in Breast Cancer Patients Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice.Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy.Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy.Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response.Systemic treatment of early breast cancer--a biological perspective.Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.Quantitative prediction of tumor response to neoadjuvant chemotherapy in breast cancer: novel marker genes and prediction model using the expression levels.Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy.Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer.Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer.Trastuzumab, non-pegylated liposomal-encapsulated doxorubicin and paclitaxel in the neoadjuvant setting of HER-2 positive breast cancer.Efficacy and safety of neoadjuvant chemotherapy with concurrent liposomal-encapsulated doxorubicin, paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive breast cancer in clinical practice.

P2860

Q35684553-FE0399E9-F9DC-4122-BC7F-593C9E206E22 Q35803615-6FAAB611-2EDE-4FD2-A77B-9EE6CFA2BB5C Q35912778-75A28C7F-E46A-4F98-8B51-70FC18D2BC3D Q36441562-D1F21A8B-613D-4F60-8097-1183184F7BCD Q36546612-852F6197-44D0-4487-9CFF-31BDF71B2359 Q37241048-F8793C83-5ED0-41E6-AFA0-6791B7A20CFB Q37289071-BF4BDE5B-2247-4C4E-841D-C0C2D6CE6644 Q37408139-243B63DC-0A1E-4A87-ADAD-2B9C0AD6B8EC Q37863638-00C2AC64-F3E3-45AF-96D0-B6DB8FBB30B7 Q38317182-FF0E78B6-4043-4CDE-B580-934473A76D06 Q39570743-2173577A-4BF0-4DF5-A34E-DDD1C893F53A Q41483585-06497FED-C57C-468A-AFB9-39BFFB4C0186 Q41716752-A5DCCB7E-A9A8-4F30-B8E2-8105DCD60926 Q43265075-FCA2A1C3-7439-4D94-A7C3-EA0E33A3045C Q47157830-822B743F-4156-4062-B9B1-C07B255E8EE0 Q47863782-CDE17F0D-C4A8-4BF7-B297-34E2205A751A Q54338904-3AB22D5A-C3CF-41D9-8299-76AA4308D3EF

P2860

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q34059719

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@ast

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@en

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@nl

type

label

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@ast

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@en

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@nl

prefLabel

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@ast

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@en

Predictors of recurrence in br ...... fter neoadjuvant chemotherapy.

@nl

P1433

Q34059719-C16B6C5B-57E7-48D1-AA43-89DF9B91BFD7

P1476

Q34059719-A9E09E08-8244-4285-A15A-3A225B0DD283

P2093

Q34059719-19F96FEF-8C11-4745-A649-389C61BA0A26

Q34059719-1A9CEF26-B293-44BD-8433-2E1A2A5E7928

Q34059719-3B7FE3A4-2035-4B0A-8A5F-95F61C24F144

Q34059719-6C60A1D5-2C5A-4591-A91D-76EDB490B350

Q34059719-7EE1A125-AFF4-4CF5-90D9-54298CBD5FB9

Q34059719-C0B4266A-F2AD-4575-920D-3083113CBABA

Q34059719-D26C4008-030B-4625-AA25-53399A761170

Q34059719-D72FCFBF-EB04-4606-AD91-69D76DA589AF

Q34059719-EA8A2AA0-EED1-4937-8199-3200312FD4F4

Q34059719-FF4664FB-C2E4-4F93-962C-172CACBBBF80

P2860

Q34059719-004BD31C-5214-46C5-A124-EDA70516C4BA

Q34059719-10BCBB29-7203-498C-9240-992ED1C2C95E

Q34059719-18D3B5CE-EE75-46B3-841A-1EE2E09EA131

Q34059719-44A895BF-5ABF-4021-83E1-1C0291BB35CC

Q34059719-721DF891-149A-46A4-857D-7F15F7B33283

Q34059719-84F52F0C-F5B1-4D13-9B0A-39CA24D1635B

Q34059719-93AE607D-2E74-4591-AEBB-43E1C477D5BD

Q34059719-9A9932A9-B7DC-4FB0-A7A6-80E8F95A7E0F

Q34059719-AB07A3E1-C4F7-4058-A41D-8F169D16DFF5

Q34059719-B908FAF6-BD29-4F02-88B2-ADE07B76972E

P2888

Q34059719-5338F50B-79F3-4B64-805E-A90DCCE5F7EB

P304

Q34059719-2CDF8BBE-7083-455C-AB81-FD3AB3319056

P31

Q34059719-E1AE2346-0976-4A74-A707-98AA65684BFC

P356

Q34059719-F4202758-B2F4-4A74-81CB-66C1D8F51AD7

P407

Q34059719-DE22DEF2-F2F3-4784-B343-B2D80C37A65C

P433

Q34059719-32F46446-9ED3-4A13-9BDB-078FF60B6962

P478

Q34059719-1B84F531-8112-47A6-A5B1-B82EEEA24D34

P50

Q34059719-04302E59-9828-46DF-A3FB-4F8A6C07F514

P577

Q34059719-2DCC3772-5F80-42EF-A701-71E73F9F7893

P5875

Q34059719-20FB8BFD-8C74-4A53-8BA4-411B5CD275DA

P6179

Q34059719-CA16ADAA-4027-4DFE-ADA0-5756C538339D

P698

Q34059719-63E20E4F-F673-4D15-A2E8-11CFD4079787

P921

Q34059719-0BA9D91D-CB83-41B3-9A92-3F6340F16D83

P932

Q34059719-AD72EE14-7CBE-4970-B312-58962774367A

P356

P1433

British Journal of Cancer

P1476

Predictors of recurrence in br ...... after neoadjuvant chemotherapy

@en

P2093

C Shimizu

http://www.w3.org/2001/XMLSchema#string

H Tsuda

http://www.w3.org/2001/XMLSchema#string

K Tamura

http://www.w3.org/2001/XMLSchema#string

K Yonemori

http://www.w3.org/2001/XMLSchema#string

K Yoshimura

http://www.w3.org/2001/XMLSchema#string

M Ando

http://www.w3.org/2001/XMLSchema#string

N Katsumata

http://www.w3.org/2001/XMLSchema#string

T Kinoshita

http://www.w3.org/2001/XMLSchema#string

T Kouno

http://www.w3.org/2001/XMLSchema#string

Y Fujiwara

http://www.w3.org/2001/XMLSchema#string

P2860

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy.

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer.

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma.

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

P2888

P304

297-302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605769

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45097629

http://www.w3.org/2001/XMLSchema#string

P6179

1027099846

http://www.w3.org/2001/XMLSchema#string

P698

20606681

http://www.w3.org/2001/XMLSchema#string

P921

P932

2920023

http://www.w3.org/2001/XMLSchema#string